Estadístiques de Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Visites totals
| views | |
|---|---|
| Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors | 52 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 4 |
| December 2024 | 2 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Garcia_jitc_phas.pdf(legacy) | 34 |
| Garcia_jitc_phas.pdf | 26 |
Vistes principals per país
| views | |
|---|---|
| United States | 38 |
| Spain | 6 |
| China | 2 |
| India | 2 |
| Argentina | 1 |
| Belgium | 1 |
| Brazil | 1 |
| France | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 14 |
| Menlo Park | 6 |
| Ann Arbor | 5 |
| Madrid | 3 |
| Barcelona | 2 |
| Fairfield | 2 |
| Mountain View | 2 |
| Ashburn | 1 |
| Beijing | 1 |
| Boardman | 1 |
| Cambridge | 1 |
| Cupertino | 1 |
| Federal | 1 |
| Meadville | 1 |
| Mumbai | 1 |
| Rochester | 1 |
| San Diego | 1 |
| Thane | 1 |
| Tiana | 1 |